Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
117M
-
Number of holders
-
146
-
Total 13F shares, excl. options
-
48.3M
-
Shares change
-
-2.84M
-
Total reported value, excl. options
-
$599M
-
Value change
-
-$47.2M
-
Put/Call ratio
-
1.63
-
Number of buys
-
63
-
Number of sells
-
-63
-
Price
-
$12.40
Significant Holders of DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) as of Q3 2018
183 filings reported holding DVAX - DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value as of Q3 2018.
DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) has 146 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.3M shares
of 117M outstanding shares and own 41.19% of the company stock.
Largest 10 shareholders include STATE STREET CORP (4.2M shares), BlackRock Inc. (4.12M shares), FRANKLIN RESOURCES INC (3.14M shares), HealthCor Management, L.P. (3.12M shares), Vanguard Group Inc (2.88M shares), Senvest Management, LLC (2.52M shares), EAGLE ASSET MANAGEMENT INC (2.3M shares), Chicago Capital, LLC (2.25M shares), D. E. Shaw & Co., Inc. (2.1M shares), and CARILLON TOWER ADVISERS, INC. (1.64M shares).
This table shows the top 146 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.